- Sectors
- Healthcare & Life Sciences
Healthcare & Life Sciences
Under Vision 2030, healthcare delivery is being reorganised around new providers, investors and partnerships. We advise local and international pharmaceutical groups, healthcare investors and Saudi shareholders on transactions and governance.

Transactions and governance for a reorganising health sector.
Public care is moving from the Ministry of Health to the Health Holding Company and its regional health clusters, the Insurance Authority now supervises health insurance, and private investment is growing through acquisitions and partnerships. Investors and operators need transactions and governance structures that fit this new allocation of roles and can adapt as it develops.
Z&Co. acts for local and international pharmaceutical groups, healthcare investors, founders and shareholders on share acquisitions, divestments and joint ventures, including registration with the Ministry of Investment (MISA) and General Authority for Competition (GAC) approval. For hospital projects and state health bodies, we advise on governance frameworks and board and committee terms of reference.
How we help clients in Healthcare & Life Sciences
Our healthcare work combines the execution of transactions under Saudi regulation with the governance that partners and state bodies need to run a venture.
Healthcare acquisitions and divestments
Acquisitions of Saudi healthcare businesses often need investment registration and GAC approval before closing. We act for buyers, sellers and target companies on share acquisitions, divestments and sales to local and foreign investors. This work draws on our mergers and acquisitions practice.
Joint ventures and hospital projects
Hospital and clinical ventures need governance that the partners can operate day to day while protecting their strategic interests. We draft shareholders' arrangements and the full suite of board and committee terms of reference for healthcare joint ventures. This work draws on our corporate joint ventures and corporate governance practices.
Competition clearances
Pharmaceutical and healthcare transactions often trigger merger control filings. We obtain GAC approvals and plan transactions around the review timetable. This work draws on our competition practice.
Governance of health bodies
State health bodies and hospital projects need governance frameworks that match current and pending regulation. We review governance manuals and charters for health procurement bodies and draft board and committee terms of reference. This work draws on our corporate governance practice.
Our selected experience in Healthcare & Life Sciences
-
Novartis International AG on its acquisition of GSK's oncology products, the combination of its over-the-counter business with GSK's consumer business in a joint venture and the sale of its Saudi vaccines business to GSK.
-
The Saudi shareholders in a private diagnostics laboratory business on the sale of a 60% equity stake to a foreign-owned UAE-based healthcare group, including the joint venture and shareholders' arrangements, the first foreign ownership investment licence for the target and General Authority for Competition approval.
-
The purchaser from Arabian International Healthcare Holding Company (Tibbiyah) on the purchase of a 51% equity interest in Innovative Healthcare Holdings Ltd. for a total consideration of SAR 52 million.
-
The owner of a major greenfield hospital project in Saudi Arabia on the governance arrangements for a proposed 50/50 joint venture, including drafting the full suite of board and committee terms of reference.



